HC Wainwright Reiterates “Buy” Rating for Caribou Biosciences (NASDAQ:CRBU)
Caribou Biosciences (NASDAQ:CRBU – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at HC Wainwright in a research report issued on Wednesday,Benzinga reports. They presently have a $9.00 target price on the stock. CRBU has been the subject of several other reports. Bank of America dropped their price target on Caribou […]
